Literature DB >> 25690426

An exceptional case of xanthomatous infiltration of the musculoskeletal and integumentary systems.

Jae W Song1, Devrim Ersahin, Melissa A Much, J Grant Thomson, Edward Smitaman.   

Abstract

Tendinous and subcutaneous xanthomas are most commonly associated with primary hyperlipidemia. Xanthomatosis caused by cholesterol deposition can be a high risk marker for cardiovascular disease related to premature atherosclerosis; thus, early recognition of this diagnosis may reduce mortality and morbidity. Achilles tendon involvement is most common, followed by the extensor tendons of the hand and elbow. We present an exceptional case of tendinous and tuberous xanthomas, with intraoperative and histologic correlation, in a 34-year-old female manifesting with xanthomatous deposits of nearly all ankle tendons, plantar aponeurosis, extensor tendons of the hands, and various locations within the integumentum. To the authors' knowledge, only four studies to date have focused specifically on imaging findings of multifocal xanthomas. Thus, the radiographic and MR imaging descriptions of xanthomas in this report further add to the existing literature by helping to identify imaging characteristics of this multifocal systemic disease. The diagnosis of this condition should alert the physician to the presence of a dyslipidemia that can be treated with dietary modifications and/or drug therapy.

Entities:  

Mesh:

Year:  2015        PMID: 25690426     DOI: 10.1007/s00256-015-2116-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  26 in total

Review 1.  Pathogenesis, detection and treatment of Achilles tendon xanthomas.

Authors:  S G Tsouli; D N Kiortsis; M I Argyropoulou; D P Mikhailidis; M S Elisaf
Journal:  Eur J Clin Invest       Date:  2005-04       Impact factor: 4.686

2.  Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia.

Authors:  K Kajinami; M Nishitsuji; Y Takeda; M Shimizu; J Koizumi; H Mabuchi
Journal:  Atherosclerosis       Date:  1996-02       Impact factor: 5.162

3.  Lipid composition of various types of xanthoma.

Authors:  H Baes; C M van Gent; C Pries
Journal:  J Invest Dermatol       Date:  1968-10       Impact factor: 8.551

4.  Xanthomatous infiltration of ankle tendons.

Authors:  C G Kelman; D G Disler; J M Kremer; T A Jennings
Journal:  Skeletal Radiol       Date:  1997-04       Impact factor: 2.199

5.  Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.

Authors:  S Lind; A G Olsson; M Eriksson; M Rudling; G Eggertsen; B Angelin
Journal:  J Intern Med       Date:  2004-11       Impact factor: 8.989

6.  Sonography of Achilles tendon xanthomas in patients with heterozygous familial hypercholesterolemia.

Authors:  N J Bureau; G Roederer
Journal:  AJR Am J Roentgenol       Date:  1998-09       Impact factor: 3.959

7.  Familial hypercholesterolaemia-like syndrome with apolipoprotein E-7 associated with marked Achilles tendon xanthomas and coronary artery disease: a report of two cases.

Authors:  Y Ueyama; S Nozaki; K Yanagi; H Hiraoka; T Nakagawa; N Sakai; S Jiao; S Yamashita; Y Matsuzawa
Journal:  J Intern Med       Date:  1994-02       Impact factor: 8.989

8.  Changes in lipid and lipoprotein levels and Achilles tendon diameters and indices in familial hypercholesterolaemic patients with tendinous xanthomatosis treated by diet and bezafibrate for 2 years.

Authors:  J Rouffy; B Chanu; R Bakir; J Goy-Loeper; F Djian; J J Monsuez; R Gomberg; M Laval-Jeantet
Journal:  Curr Med Res Opin       Date:  1988       Impact factor: 2.580

9.  Diagnosis of Achilles tendon xanthoma in patients with heterozygous familial hypercholesterolemia: MR vs sonography.

Authors:  R O Bude; R S Adler; D R Bassett
Journal:  AJR Am J Roentgenol       Date:  1994-04       Impact factor: 3.959

10.  Thomas Addison (1793-1860).

Authors:  J M S Pearce
Journal:  J R Soc Med       Date:  2004-06       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.